BCR-ABL transcript variant's significance in chronic myeloid leukemia in chronic phase: Institutional experience from a developing country

被引：0
|
作者：
Prasad, S. K. [1 ]
Chennamaneni, R. [1 ]
Stalin, B. [1 ]
Konatam, M. L. [1 ]
Gundeti, S. [1 ]
机构：
[1] Nizams Inst Med Sci, Med Oncol, Hyderabad, India
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1099P
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [41] Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia
    Sherbenou, D. W.
    Hantschel, O.
    Turaga, L.
    Kaupe, I.
    Willis, S.
    Bumm, T.
    Press, R. D.
    Superti-Furga, G.
    Druker, B. J.
    Deininger, M. W.
    LEUKEMIA, 2008, 22 (06) : 1184 - 1190
  • [42] Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia
    D W Sherbenou
    O Hantschel
    L Turaga
    I Kaupe
    S Willis
    T Bumm
    R D Press
    G Superti-Furga
    B J Druker
    M W Deininger
    Leukemia, 2008, 22 : 1184 - 1190
  • [43] Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts
    Pratibha Sharma
    Lalit Kumar
    Sujata Mohanty
    Vinod Kochupillai
    Annals of Hematology, 2010, 89 : 241 - 247
  • [44] Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase
    Rosti, Gianantonio
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Palandri, Francesca
    Baccarani, Michele
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 (02) : 159 - 170
  • [45] A case of chronic myeloid leukemia with minor bcr-abl transcript following fluorouracil therapy for esophageal carcinoma
    Nakamura, H
    Inokuchi, K
    Hanawa, H
    Yamaguchi, H
    Tamura, H
    Tajika, K
    Dan, K
    ANNALS OF HEMATOLOGY, 2000, 79 (07) : 396 - 401
  • [46] A case of chronic myeloid leukemia with minor bcr-abl transcript following fluorouracil therapy for esophageal carcinoma
    H. Nakamura
    K. Inokuchi
    H. Hanawa
    H. Yamaguchi
    H. Tamura
    K. Tajika
    K. Dan
    Annals of Hematology, 2000, 79 : 396 - 401
  • [47] Impact of the type of the BCR-ABL fusion transcript on the molecular response in pediatric patients with chronic myeloid leukemia
    Suttorp, Meinolf
    Thiede, Christian
    Tauer, Josephine T.
    Range, Ursula
    Schlegelberger, Brigitte
    von Neuhoff, Nils
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05): : 852 - 853
  • [48] A novel BCR-ABL fusion transcript (e18a2) in a child with chronic myeloid leukemia
    van der Velden, V. H. J.
    Beverloo, H. B.
    Hoogeveen, P. G.
    Zwaan, Ch M.
    LEUKEMIA, 2007, 21 (04) : 833 - 835
  • [49] e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
    Colla, S
    Sammarelli, G
    Voltolini, S
    Crugnola, M
    Sebastio, P
    Giuliani, N
    HAEMATOLOGICA, 2004, 89 (05) : 611 - 613
  • [50] Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts
    Sharma, Pratibha
    Kumar, Lalit
    Mohanty, Sujata
    Kochupillai, Vinod
    ANNALS OF HEMATOLOGY, 2010, 89 (03) : 241 - 247
12345